Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS Health Corporation (NYSE: CVS) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also raised FY21 EPS guidance above estimates.

Why Are CVS Shares Trading Higher Today?

As a frontline healthcare company, it is impossible for CVS not to look back to a year ago, when the early stages of COVID lockdowns had store shelves picked bare as consumers panic-bought everything from hand sanitizer to toilet paper in an effort to prepare for the unknown. Fast-forward to 2021, and the Rhode Island-based […]

CVS Grinds Out Revenue Growth In The Face Of Year-Ago COVID Comps

All of the company's segments delivered solid growth.

How CVS Health Beat Expectations in Q1

CVS Health reported more than $2 billion in first quarter profits thanks to an influx of customers seeking Covid-19 diagnostic tests and vaccines.

CVS Profits Jump As Customers Flock To Covid-19 Vaccines, Tests

CVS Health beat Wall Street expectations and after releasing projections earlier this year that disappointed analysts, a new outlook Tuesday exceeds those levels.

CVS raises outlook on COVID-19, Medicare products

CVS Health (CVS) delivered earnings and revenue surprises of 18.60% and 0.96%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

CVS Health (CVS) Q1 Earnings and Revenues Top Estimates

CVS Health Corp. (NYSE: CVS) said on Tuesday that its profit and sales came in better than expected in the fiscal first quarter as all of its business segments showed resilience in recent months. On the back of hawkish quarterly performance, the company raised its guidance for the full financial year.

3 key takeaways from CVS Health's Q1 earnings report

CVS Health Corporation (NYSE: CVS) shares moved higher in the premarket after the company reported better than expected Q1 earnings. Overall revenues increased 3.5% Y/Y to $69.1 billion, driven by growth across all segments.

CVS Health Shares Are Trading Higher On Q1 Earnings Beat, Raised FY21 EPS Guidance

CVS Health outpaced analysts' expectations for first-quarter earnings and revenue.

CVS Health earnings beats expectations for first quarter, raises forecast for year

Shares of CVS Health Corp. rallied 3.6% toward a 2 1/2-year high in premarket trading Tuesday, after the drugstore chain and health care services company reported first-quarter profit and sales that rose above expectations, with growth in all segments, and raised its full-year outlook. Net income rose to $2.22 billion, or $1.68 a share, from $2.01 billion, or $1.53 a share, in the year-ago period.

CVS stock surges to multiyear high after profit and revenue beats, raised outlook

CVS Health Corp reported a 10.5% rise in first-quarter profit on Tuesday, helped in part by higher sales at its drug stores, with more customers seeking COVID-19 tests and vaccinations.

CVS Health profit rises nearly 11% on drug store sales

Cummins

Mosaic

Pfizer

T-Mobile US

Some of the stocks that may grab investor focus today are: Wall Street expects CVS Health Corp (NYSE: CVS) to report quarterly earnings at $1.71 per share on revenue of $68.39 billion before the opening bell. CVS shares rose 2.5% to $79.66 in after-hours trading.

5 Stocks To Watch For May 4, 2021

Rite Aid

Walgreens

The drugstore chains are also expanding community clinics and signing deals with employers to reach Americans who may be busy or hesitant.

Major drugstore chains offer same-day Covid vaccines as eligibility increases and immunization pace slows

Air Lease

Investors Bancorp

Kroger

Silgan Hlds

As markets continue to hit record highs, it's more about finding fairly valued companies than great bargains. Stocks that look like bargains right now have issues and concerns surrounding them. Be sure to do your due diligence.

Where A Dividend Growth Investor Can Find Value In May

WOONSOCKET, R.I., May 3, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced new initiatives to support women's health and wellness in May, including offering no-cost heart health screenings from May 9 through May 15 at MinuteClinic to help women understand their risk for heart disease – the number one killer of women.

CVS Health Announces New Initiatives to Support Women's Health and Wellness in May

Under Armour

Ballard Power Systems

SolarEdge Technologies

More than 900 publicly traded companies are scheduled to report March quarter earnings next week, with heavy representation from energy exploration and production companies.

Earnings Previews: CVS, Pfizer, Under Armour and More

CVS Group PLC (LON:CVSG) galloped 9% higher to 184p at lunchtime after upgrading expectations for full-year revenue and adjusted underlying earnings (EBITDA). The veterinary services provider said sales are remaining strong and there has been a steady increase in customer demand since the end of March.

CVS Group gallops after revenue, profit upgrade

WOONSOCKET, R.I., April 30, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) announced today it has launched an expansion of Project Health, the company's no-cost, community-based screening program, which helps people without regular access to health care understand their risk for chronic conditions and connect to free or low-cost providers and services to support their unique health care needs.

CVS Health Expands No-Cost Health Screening Program, Advancing Company's Commitment to Address Health Equity and Disparities

CVS Group PLC (LON:CVSG) said full-year revenue and adjusted underlying earnings (EBITDA) will top management expectations. The veterinary services provider said sales are remaining strong and there has been a steady increase in customer demand since the end of March.

CVS Group raises full-year revenue, earnings expectations after strong run

CVS Health (NYSE: CVS) has inaugurated CVS Health Ventures, a corporate venture capital fund aimed at creating partnerships with early-stage companies focused on improving the accessibility and affordability of health care. What Happened: According to the Woonsocket, Rhode Island-based company, the fund will begin with $100 million allocated for investments.

CVS Health Debuts $100M Venture Capital Fund For Early-Stage Health Care Companies

The shares of CVS Health Corp (NYSE:CVS) have faced continued pressure at the $78 region, making a few attempts to topple the ceiling over the last few years, including on April 21, when the stock rose to $77.44 -- its highest level since late 2018.

History Says CVS Stock's Pullback Could Work Out

CVS Health Corp. said Thursday that it will launch CVS Health Ventures, a venture fund that invests in and partners with early-stage companies focused on making healthcare more accessible and affordable. Starting with $100 million, the initial focus will be on tech-enabled and digital healthcare companies.

CVS launching $100 million venture fund

WOONSOCKET, R.I., April 29, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced the launch of CVS Health Ventures, a dedicated corporate venture capital fund that will invest in and partner with high-potential, early-stage companies focused on making health care more accessible, affordable, and simpler.

CVS Health Launches $100 Million Venture Fund

WOONSOCKET, R.I., April 29, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced it recently began administering COVID-19 vaccines at employer-based vaccination clinics through Return Ready, helping to increase access to vaccinations for employees following expanded eligibility to all adults in the United States and an increasing vaccine supply.

CVS Health Teams Up with U.S. Employers to Simplify Access to COVID-19 Vaccines and Help Bring People Back to Work

Given the increasing number of walk-in-clinical appointments and patient visits, CVS Health (CVS), which has a huge PBM client base, is expected to have seen a sequential rebound in Q1 revenues.

News for CVS Health Stock (CVS)